Karagiannakis, D.S.; Stefanaki, K.; Petrea, F.; Zacharaki, P.; Giannou, A.; Michalopoulou, O.; Kazakou, P.; Psaltopoulou, T.; Vasileiou, V.; Paschou, S.A.
Elevated FIB-4 Is Associated with Higher Rates of Cardiovascular Disease and Extrahepatic Cancer History in Patients with Type 2 Diabetes Mellitus. Biomedicines 2024, 12, 823.
https://doi.org/10.3390/biomedicines12040823
AMA Style
Karagiannakis DS, Stefanaki K, Petrea F, Zacharaki P, Giannou A, Michalopoulou O, Kazakou P, Psaltopoulou T, Vasileiou V, Paschou SA.
Elevated FIB-4 Is Associated with Higher Rates of Cardiovascular Disease and Extrahepatic Cancer History in Patients with Type 2 Diabetes Mellitus. Biomedicines. 2024; 12(4):823.
https://doi.org/10.3390/biomedicines12040823
Chicago/Turabian Style
Karagiannakis, Dimitrios S., Katerina Stefanaki, Foteini Petrea, Panagiota Zacharaki, Alexandra Giannou, Olympia Michalopoulou, Paraskevi Kazakou, Theodora Psaltopoulou, Vasiliki Vasileiou, and Stavroula A. Paschou.
2024. "Elevated FIB-4 Is Associated with Higher Rates of Cardiovascular Disease and Extrahepatic Cancer History in Patients with Type 2 Diabetes Mellitus" Biomedicines 12, no. 4: 823.
https://doi.org/10.3390/biomedicines12040823
APA Style
Karagiannakis, D. S., Stefanaki, K., Petrea, F., Zacharaki, P., Giannou, A., Michalopoulou, O., Kazakou, P., Psaltopoulou, T., Vasileiou, V., & Paschou, S. A.
(2024). Elevated FIB-4 Is Associated with Higher Rates of Cardiovascular Disease and Extrahepatic Cancer History in Patients with Type 2 Diabetes Mellitus. Biomedicines, 12(4), 823.
https://doi.org/10.3390/biomedicines12040823
